West Branch Capital’s PetMed Express PETS Stock Holding History

West Branch Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-125	Closed	-$2K	–	469
2022 Q3	$2K	Buy	+125	New	+$2.65K	﹤0.01%	408

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

West Branch Capital's PETS Position: Q4 2022 in Review

West Branch Capital sold out of PetMed Express (PETS) in Q4 2022, closing a stake of 125 shares — an estimated $2K sold.

West Branch Capital first reported a position in PETS in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 162 funds tracked by Wall St. Rank hold PETS as of Q4 2022.

West Branch Capital reported no remaining PetMed Express position as of Q4 2022 after selling out during the quarter.
West Branch Capital sold 125 PetMed Express shares in Q4 2022, an estimated $2K.
West Branch Capital first reported a position in PetMed Express in Q3 2022 and held it in 1 quarter.
West Branch Capital's PetMed Express position peaked at $2K in Q3 2022.
162 funds tracked by Wall St. Rank held PetMed Express as of Q4 2022.

Based on West Branch Capital's 13F filing for Q4 2022, filed 27 Jan 2023.